Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1981 Nov;46(2):382–390.

Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.

R Meliconi, M Baraldini, G F Stefanini, A Facchini, F Miglio, F Bortolotti, A Alberti, G Realdi, P Amoroso
PMCID: PMC1536384  PMID: 6802539

Abstract

Sera from 42 patients with acute viral hepatitis (AVH), 97 patients with chronic active liver disease (CALD) and 89 controls were tested by radioimmunoprecipitation for the presence of antibodies against human liver-specific protein (LSP). Anti-LSP were found in all but one patient with AVH type A (93%) and in a smaller percentage of AVH type B (55%). In non-A, non-B cases, anti-LSP were found in low percentages: 27% in acute cases, 10% in chronic cases. Furthermore, in CALD, a significant difference was found between HBsAg-positive CAH and 'autoimmune' CAH, a significant difference was found between HBsAg-positive CAH and 'autoimmune' CAH, both in anti-LSP prevalence (21%, 67%; P less than 0.005) and in anti-LSP titre (1:154 +/- 170, 1:316 +/- 186; P less than 0.005). In HBsAg-negative/anti-HBc-positive CAH, three of 15 patients were anti-LSP positive. Anti-LSP were found only in three of 57 patients with various non-hepatic diseases with autoimmune features. None of the 12 healthy HBsAg carriers was positive. Hence there is evidence for a considerable heterogeneity in anti-LSP response in acute and in chronic inflammatory HBsAg-negative liver diseases. These data suggest that anti-LSP antibodies do not play a prominent role in the process of transition to chronicity of acute viral hepatitis particularly in non-A, non-B cases, whereas these antibodies may be important in the mechanism of ongoing liver cell injury in patients with 'autoimmune' CAH, and can represent a useful diagnostic marker of this type of hepatitis.

Full text

PDF
382

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrass C. K., Border W. A., Hepner G. Non-specificity of circulating immune complexes in patients with acute and chronic liver disease. Clin Exp Immunol. 1980 May;40(2):292–298. [PMC free article] [PubMed] [Google Scholar]
  2. Alter H. J., Purcell R. H., Holland P. V., Popper H. Transmissible agent in non-A, non-B hepatitis. Lancet. 1978 Mar 4;1(8062):459–463. doi: 10.1016/s0140-6736(78)90131-9. [DOI] [PubMed] [Google Scholar]
  3. Behrens U. J., Paronetto F. Studies on "liver-specific" antigens. I. Evaluation of the liver specificity of "LSP" and "LP-2". Gastroenterology. 1979 Nov;77(5):1045–1052. [PubMed] [Google Scholar]
  4. Bianchi P., Porro C. B., Coltorti M., Dardanoni L., Del Vecchio Blanco C., Fagiolo U., Farini R., Menozzi I., Naccarato R., Pagliaro L. Occurrence of Australia antigen in chronic hepatitis in Italy. Gastroenterology. 1972 Sep;63(3):482–485. [PubMed] [Google Scholar]
  5. Cochrane A. M., Moussouros A., Smith A., Thomson A. D., Eddleston A. L., Williams R. Autoimmune reaction to a liver specific membrane antigen during acute viral hepatitis. Gut. 1976 Sep;17(9):714–718. doi: 10.1136/gut.17.9.714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cochrane A. M., Moussouros A., Thomsom A. D., Eddleston A. L., Wiiliams R. Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis. Lancet. 1976 Feb 28;1(7957):441–444. doi: 10.1016/s0140-6736(76)91472-0. [DOI] [PubMed] [Google Scholar]
  7. Dienstag J. L., Bhan A. K., Alter H. J., Feinstone S. M., Purcell R. H. Circulating immune complexes in non-A, non-B hepatitis. Possible masking of viral antigen. Lancet. 1979 Jun 16;1(8129):1265–1267. doi: 10.1016/s0140-6736(79)92228-1. [DOI] [PubMed] [Google Scholar]
  8. Dienstag J. L., Isselbacher K. J. Liver-specific protein: more questions than answers. N Engl J Med. 1978 Jul 6;299(1):40–42. doi: 10.1056/NEJM197807062990110. [DOI] [PubMed] [Google Scholar]
  9. Facchini A., Stefanini G. F., Bernardi M., Miglio F., Gasbarrini G., Labö G. Lymphocytotoxicity test against rabbit hepatocytes in chronic liver diseases. Gut. 1978 Mar;19(3):189–193. doi: 10.1136/gut.19.3.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jensen D. M., McFarlane I. G., Portmann B. S., Eddleston A. L., Williams R. Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med. 1978 Jul 6;299(1):1–7. doi: 10.1056/NEJM197807062990101. [DOI] [PubMed] [Google Scholar]
  11. Kakumu S., Arakawa Y., Goji H., Kashio T., Yata K. Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases. Gastroenterology. 1979 Apr;76(4):665–672. [PubMed] [Google Scholar]
  12. Manns M., Meyer zum Büschenfelde K. H., Hess G. Autoantibodies against liver-specific membrane lipoprotein in acute and chronic liver diseases: studies on organ-, species-, and disease-specificity. Gut. 1980 Nov;21(11):955–961. doi: 10.1136/gut.21.11.955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McFarlane I. G., Wojcicka B. M., Zucker G. M., Eddleston A. L., Williams R. Purification and characterization of human liver-specific membrane lipoprotein (LSP). Clin Exp Immunol. 1977 Mar;27(3):381–390. [PMC free article] [PubMed] [Google Scholar]
  14. Meyer zum Büschenfelde K. H., Manns M., Hütteroth T. H., Hopf U., Arnold W. LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis? Clin Exp Immunol. 1979 Aug;37(2):205–212. [PMC free article] [PubMed] [Google Scholar]
  15. Miller J., Smith M. G., Mitchell C. G., Reed W. D., Eddleston A. L., Williams R. Cell-mediated immunity to a human liver-specific antigen in patients with active chronic hepatitis and primary biliary cirrhosis. Lancet. 1972 Aug 12;2(7772):296–297. doi: 10.1016/s0140-6736(72)92904-2. [DOI] [PubMed] [Google Scholar]
  16. Mosley J. W., Redeker A. G., Feinstone S. M., Purcell R. H. Mutliple hepatitis viruses in multiple attacks of acute viral hepatitis. N Engl J Med. 1977 Jan 13;296(2):75–78. doi: 10.1056/NEJM197701132960204. [DOI] [PubMed] [Google Scholar]
  17. Ortona L., Laghi V., Cauda R., Nervo P. Lymphocyte transformation test with rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis. Clin Exp Immunol. 1979 Nov;38(2):231–234. [PMC free article] [PubMed] [Google Scholar]
  18. Rakela J., Redeker A. G. Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterology. 1979 Dec;77(6):1200–1202. [PubMed] [Google Scholar]
  19. Shirachi R., Shiraishi H., Tateda A., Kikuchi K., Ishida N. Hepatitis "C" antigen in non-A, non-B post-transfusion hepatitis. Lancet. 1978 Oct 21;2(8095):853–856. doi: 10.1016/s0140-6736(78)91567-2. [DOI] [PubMed] [Google Scholar]
  20. Thomas H. C., De Villiers D., Potter B., Hodgson H., Jain S., Jewell D. P., Sherlock S. Immune complexes in acute and chronic liver disease. Clin Exp Immunol. 1978 Feb;31(2):150–157. [PMC free article] [PubMed] [Google Scholar]
  21. Thomson A. D., Cochrane M. A., McFarlane I. G., Eddleston A. L., Williams R. Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis. Nature. 1974 Dec 20;252(5485):721–722. doi: 10.1038/252721a0. [DOI] [PubMed] [Google Scholar]
  22. Tremolada F., Fattovich G., Panebianco G., Ongaro G., Realdi G. Suppressor cell activity in viral and non-viral chronic active hepatitis. Clin Exp Immunol. 1980 Apr;40(1):89–95. [PMC free article] [PubMed] [Google Scholar]
  23. Tsantoulas D., Perperas A., Portmann B., Eddleston A. L., Williams R. Antibodies to a human liver membrane lipoprotein (LSP) in primary biliary cirrhosis. Gut. 1980 Jul;21(7):557–560. doi: 10.1136/gut.21.7.557. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES